The United States boasts a diverse pharmaceutical industry, particularly when it comes to the production of active pharmaceutical ingredients (APIs). Among these APIs, tirzepatide has gained significant prominence due to its potential in treating type 2 diabetes and other metabolic disorders. Several companies have emerged as leading manufacturers